Open AccessEffects of the Selective Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin on Vascular Function and Central Hemodynamics in Patients With Type 2 Diabetes Mellitus
Author(s) -
Kristina Striepe,
Agnes Jumar,
Christian Ott,
Marina V. Karg,
Markus P. Schneider,
Dennis Kannenkeril,
Roland E. Schmieder
Publication year - 2017
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.117.029529
Subject(s) - empagliflozin , medicine , diabetes mellitus , type 2 diabetes mellitus , cotransporter , canagliflozin , hemodynamics , type 2 diabetes , pharmacology , endocrinology , cardiology , sodium , chemistry , organic chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom